Staff

FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners...

SEOULTECH Researchers Develop Revolutionary 3D-Printed Smart Materials Create High-Performance Pressure Sensors for Wearables

Breakthrough metamaterial technology leads to next-generation wearable devices and health monitoring SEOUL, South Korea, Aug. 29, 2025 /PRNewswire/ -- Tactile sensors are...

error: Content is protected !!